NCT06014762
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06014762
Title P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Poseida Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Loma Linda University Cancer Center Loma Linda California 92354 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Advent Health Orlando Orlando Florida 32803 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
Our Lady of the Lake Hospital Baton Rouge Louisiana 70808 United States Details
Ochsner Clinic Foundation New Orleans Louisiana 70121 United States Details
Wayne State - Karmanos Cancer Institute Detroit Michigan 48201 United States Details
NYU Grossman School of Medicine New York New York 10016 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
University of Cincinnati Cincinnati Ohio 45206 United States Details
University of Oklahoma, Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Pennsylvania State University Hershey Pennsylvania 17033 United States Details
Prisma Health - Upstate Cancer Institute Greenville South Carolina 29605 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Baylor Scott & White Research Institute Dallas Texas 75204 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field